Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 996 across all filing types
Latest filing 2026-06-05 Board/Management Inform…
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj:n hallituksen järjestäytyminen
Board/Management Information Classification · 95% confidence The document is a short announcement detailing the organization of Biohit Oyj’s board following a board meeting, specifically the election of the board chairman. This is a change/organization of the board of directors, fitting the ‘Board/Management Information’ category (MANG). There is no financial data or report publication reference; it is purely an announcement of management change.
2026-06-05 Finnish
Constitutive meeting of Biohit Oyj's Board of Directors
Board/Management Information Classification · 92% confidence The document is a brief announcement by Biohit Oyj reporting that at the constitutive meeting of its Board of Directors, Professor Kari Syrjänen was elected Chairman. This is a clear announcement of a change in the company’s board leadership, fitting the ‘Board/Management Information’ category.
2026-06-05 English
Biohit Oyj:n varsinaisen yhtiökokouksen päätökset
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a summary of resolutions passed at Biohit Oyj’s Annual General Meeting on June 3, 2026, detailing votes on discharge of liability, dividend, board elections, auditor appointment, and share issue authorization. This is a post-meeting announcement of voting decisions at the AGM rather than the meeting materials themselves or a full annual report. It falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-03 Finnish
Decisions of the Annual General Meeting of Biohit Oyj
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document clearly presents the official decisions taken at the Annual General Meeting, detailing vote outcomes on financial statements, board elections, dividends, auditor appointment, share authorizations, etc. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-03 English
Korjaus: Biohit Oyj:n yhtiökokouskutsu
AGM Information Classification · 95% confidence The document is a detailed notice and correction of the Annual General Meeting (AGM) invitation for Biohit Oyj, including the agenda items to be discussed at the AGM such as approval of the financial statements, election of board members, remuneration proposals, and authorization for share issues. It also includes instructions for shareholders on participation and voting. The document does not contain the actual annual report, financial statements, or audit reports but rather the meeting notice and agenda. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including meeting invitations and agendas. The document length is over 12,000 characters, indicating it is not a brief announcement but a full AGM invitation and agenda. Therefore, the correct classification is AGM-R with high confidence.
2026-05-06 Finnish
Correction: Notice of Biohit Oyj's Annual General Meeting
AGM Information Classification · 100% confidence The document is a detailed notice and correction for Biohit Oyj's Annual General Meeting (AGM) scheduled for June 3, 2026. It includes the agenda items typical for an AGM notice such as election of board members, adoption of financial statements, remuneration proposals, and authorizations for share issuance. It also provides instructions for shareholders on participation and registration. The document does not contain the actual financial statements or reports but references where these can be found. The content is consistent with a formal AGM notice and correction rather than the AGM materials themselves or the results of the meeting. Therefore, the document fits the category of AGM Information (AGM-R).
2026-05-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.